Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98.4M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
53.5M
-
Shares change
-
+338K
-
Total reported value, excl. options
-
$153M
-
Value change
-
+$890K
-
Put/Call ratio
-
0.06
-
Number of buys
-
50
-
Number of sells
-
-32
-
Price
-
$2.86
Significant Holders of Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) as of Q3 2024
111 filings reported holding PSTX - Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.5M shares
of 98.4M outstanding shares and own 54.4% of the company stock.
Largest 10 shareholders include FMR LLC (14.6M shares), Pentwater Capital Management LP (5.98M shares), BlackRock, Inc. (5.12M shares), SILVERARC CAPITAL MANAGEMENT, LLC (3.69M shares), VANGUARD GROUP INC (3.66M shares), MILLENNIUM MANAGEMENT LLC (2.19M shares), Boxer Capital, LLC (2M shares), STATE STREET CORP (1.71M shares), GEODE CAPITAL MANAGEMENT, LLC (1.62M shares), and BLAIR WILLIAM & CO/IL (1.11M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.